Edition:
United States

Aimmune Therapeutics Inc (AIMT.OQ)

AIMT.OQ on NASDAQ Stock Exchange Global Select Market

31.95USD
23 Apr 2018
Change (% chg)

$0.32 (+1.01%)
Prev Close
$31.63
Open
$31.79
Day's High
$32.25
Day's Low
$31.36
Volume
149,077
Avg. Vol
276,676
52-wk High
$41.75
52-wk Low
$15.97

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.73 December 24 Apr 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 3 3 3
(2) OUTPERFORM 6 6 5 5
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.75 1.67 1.62 1.62

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Jun-18 7 0.00 0.00 0.00 0.00
Quarter Ending Sep-18 7 0.00 0.00 0.00 0.00
Year Ending Dec-18 7 0.00 0.00 0.00 15.10
Year Ending Dec-19 8 41.33 142.01 0.00 40.65
Earnings (per share)
Quarter Ending Jun-18 7 -0.73 -0.60 -0.89 -0.78
Quarter Ending Sep-18 7 -0.77 -0.60 -0.96 -0.87
Year Ending Dec-18 8 -2.94 -2.33 -3.69 -3.23
Year Ending Dec-19 6 -2.52 -1.57 -3.62 -2.25

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Dec-17 0.00 0.00 0.00 0.00
Quarter Ending Sep-17 0.00 0.00 0.00 0.00
Quarter Ending Jun-17 0.00 0.00 0.00 0.00
Quarter Ending Mar-17 0.00 0.00 0.00 0.00
Quarter Ending Dec-16 0.00 0.00 0.00 0.00

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Jun-18 0.00 0.00 0.00 0.00 0.00
Quarter Ending Sep-18 0.00 0.00 0.00 0.00 0.00
Year Ending Dec-18 0.00 0.00 0.00 0.00 15.10
Year Ending Dec-19 41.33 41.33 36.92 48.91 40.65

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Jun-18 0 0 0 0
Quarter Ending Sep-18 0 0 0 0
Year Ending Dec-18 0 0 0 0
Year Ending Dec-19 0 0 0 0
Earnings